Feature | November 04, 2016| Dave Fornell

Most Popular DAIC Content in October 2016

One of the most popular articles on October was a post-procedure MRI study of transcatheter aortic valve replacement (TAVR) patients. It showed that showed 94 percent of patients have minor lesions in the brain due to procedural emboli. This has spurred additional interest in using embolic protection systems during TAVR procedures. 

November 4, 2016 — Here is the list of the top 20 most popular pieces of content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of October based on website analytics:  

1. 5 New Implantable Cardiovascular Technologies to Watch
 

2. Study Shows New Brain Lesions in 94 Percent of Patients Following TAVR
 

3. St. Jude Medical Recalls ICDs and CRT-D Due to Premature Battery Depletion
 

4. Improving Efficiencies With a Radial Access Sleeve Drape
 

5. St. Jude Medical, Abbott to Sell Portion of Vascular Closure, EP Businesses to Terumo
 

6. Study Shows Zip Skin Closure System Saves Time in the Cath Lab
 

7. Understanding the Design and Function of Guidewire Technology
 

8. Stents, Bypass Surgery Equally Safe and Effective for Many with Left Main Heart Disease
 

9. Updated ASE Guideline Simplifies Evaluation of Possible Heart Failure
 

10. Better Prognosis for Some PCI Patients When Operators Perform More Procedures
 

11. Requirements for Interventional Echocardiographers
 

12. First Bioresorbable Heart Valves Implanted to Enable Cardiovascular Restoration
 

13. What You Need to Know to Prepare for TCT 2016
 

14. FDA Changes Rules For Custom Medical Device Exemptions
 

15. Vascular Solutions Issues Recall of Twin-Pass Dual Access Catheters
 

16. 5 Technologies to Reduce Cath Lab Radiation Exposure
 

17. University Hospital Zurich Heart Team First to Perform Tricuspid Valve Repair with Cardioband
 

18. Late-Breaking Endovascular Clinical Trial Results Announced At VIVA 16
 

19. New Smartphone App Detects Heart Attacks
 

20. Robotics May Aid Implantation of Bioresorbable Stents
 

Related Content

Earlier Intervention for Mitral Valve Disease May Lead to Improved Outcomes
News | Heart Valve Technology | July 26, 2018
The number of patients undergoing mitral valve operations are at an all-time high, and new research suggests many...
The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system  is being tested in the SUMMIT Trial.

The Abbott Tendyne transcatheter mitral valve replacement (TMVR) system.

Feature | Heart Valve Technology | July 26, 2018
July 26, 2018 — The pivotal clinical study in the U.S.
A CoreValve TAVR valve seen in a CT scan looking down from the aortic arch into the left ventricle using reconstruction software from TeraRecon.

A CoreValve TAVR valve seen in a CT scan looking down from the aortic arch into the left ventricle using reconstruction software from TeraRecon.

Feature | Heart Valve Technology | July 26, 2018
July 26, 2018 — A new multi-societal expert consensus document has been released that summarizes the position of thes
Abbott Receives FDA Approval for Third-Generation MitraClip Device
Technology | Heart Valve Technology | July 18, 2018
July 18, 2018 — Abbott announced it received approval from the U.S.
Videos | Heart Valve Technology | July 18, 2018
Jonathon Leipsic, M.D., FSCCT, professor of radiology and cardiology at the University of British Columbia, Vancouver
Videos | Heart Valve Technology | July 10, 2018
Ori Ben-Yehuda, M.D., executive director of the Cardiovascular Research Foundation Clinical Trial Center, discusses t
Videos | Heart Valve Technology | July 05, 2018
Rebecca Hahn, M.D., professor of medicine and director of interventional echocardiography, Columbia University Medica
Henry Ford Hospital First in Michigan to Perform Cardioband Mitral Valve Procedure

An angiography image showing the catheter-based implantation of the Cardioband annuloplasty ring using corkscrew shaped anchors.

News | Heart Valve Technology | June 13, 2018
Henry Ford Hospital is one of 17 U.S. trial sites using a catheter-based procedure approved in Europe to repair a leaky...
Abbott Portico transcatheter aortic valve replacement (TAVR) performed well PORTICO I real-world study. #EuroPCR
News | Heart Valve Technology | June 01, 2018
June 1, 2018 –  Use of the Abbott Portico transcatheter aortic valve replacement (TAVR) therapy was associated with e
Tendyne Transcatheter Mitral Valve Replacement Device Demonstrates Positive 30-Day Outcomes
News | Heart Valve Technology | May 25, 2018
Abbott announced favorable outcomes from the first 100 patients treated in a global study of its Tendyne Transcatheter...
Overlay Init